Observational study on genetic lipid disorders in Italy

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

LIPIGEN is an observational study that involves Italian physicians and researchers focusing on familial dyslipidaemias, particularly familial hypercholesterolaemia (FH). The study collects data from patients during their routine clinical examinations without introducing additional procedures. It aims to enhance the understanding of FH and related conditions by examining clinical diagnoses, genetic testing, and treatment effectiveness. The research also seeks to identify genetic mutations responsible for these disorders to inform more effective treatment strategies.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Molecular or clinical diagnosis of genetic dyslipidemia
* Informed consent signed

Exclusion Criteria:

* None

Where it's running

• IRCCS Multimedica
  Sesto San Giovanni, Milano, Italy Recruiting

Study contacts

• Study coordinator: Manuela Casula, PhD
• Email: manuela.casula@unimi.it
• Phone: +390250318428

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• ORIGIN-FH: Newborn screening to detect familial high cholesterol

  This project will test a genetic cheek swab of parents plus blood screening of newborns to find familial high cholesterol in babies born to parents with familial hypercholesterolemia.

  Recruiting University of Wisconsin, Madison · Madison, Wisconsin · NCT07470723

• Gene testing for diagnosing and treating heart disease

  This study is trying to see if gene testing can help doctors better diagnose and treat heart conditions related to arrhythmias in patients at the Cardiogenetic Center in Italy.

  Recruiting University Hospital of Ferrara · Ferrara · NCT06898307

• Registry for hereditary cardiovascular diseases in Brazil

  This study is trying to create a registry of Brazilian patients with hereditary heart diseases to see how common certain genetic changes are in people with these conditions.

  Recruiting at 27 sites Hospital do Coracao · Rio Branco, Acre and 26 other locations · NCT06546137

• Exploring YOLT-101 for treating Familial Hypercholesterolemia

  This study is testing a new treatment called YOLT-101 to see if it can safely lower cholesterol levels in people with familial hypercholesterolemia.

  Recruiting Early Phase 1 RenJi Hospital · Shanghai, Shanghai Municipality · NCT06458010

• Atlantic program to optimize cholesterol-lowering care

  This program will try coordinated outreach with primary care providers to lower LDL-C in people with familial hypercholesterolemia or LDL-C ≥160 mg/dL.

  Recruiting Atlantic Health System · Clark, New Jersey and 1 other locations · NCT06439654

• Improving detection of familial hypercholesterolemia through lab comments on cholesterol levels

  This study is testing if adding helpful comments about high cholesterol levels in lab reports can lead to more people being referred for familial hypercholesterolemia diagnosis and treatment in Southern Denmark.

  Recruiting at 2 sites Odense University Hospital · Odense, Funen and 1 other locations · NCT05614219

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.